Atea Pharmaceuticals (AVIR) director reports RSU vesting and new option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Atea Pharmaceuticals director Polly A. Murphy reported equity compensation activity and an RSU vesting-related share delivery. On June 18, 2026, RSUs covering 29,600 shares of common stock were exercised into common stock, leaving her with 121,745 common shares directly held.
On the same date, she received a stock option grant for 37,700 shares of common stock at an exercise price of $4.36 per share, vesting in twelve substantially equal monthly installments through June 18, 2027, and expiring on June 17, 2036. She was also granted 26,700 restricted stock units, each representing one share of common stock, vesting in a single installment on the earlier of the next annual stockholder meeting after June 18, 2026 or June 18, 2027, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
29,600 shares exercised/converted
Mixed
4 txns
Insider
Murphy Polly A.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 29,600 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 26,700 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 37,700 | $0.00 | -- |
| Exercise | Common Stock | 29,600 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct, null);
Stock Option (Right to Buy) — 37,700 shares (Direct, null);
Common Stock — 121,745 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested in full on June 18, 2026. The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date. The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Key Figures
RSUs converted to common: 29,600 shares
Common shares held after: 121,745 shares
New stock option grant: 37,700 options
+4 more
7 metrics
RSUs converted to common
29,600 shares
Restricted stock units exercised into common stock on June 18, 2026
Common shares held after
121,745 shares
Direct holdings after RSU exercise on June 18, 2026
New stock option grant
37,700 options
Right to buy common stock granted on June 18, 2026
Option exercise price
$4.36 per share
Conversion or exercise price for 37,700 stock options
Option expiration
June 17, 2036
Expiration date for 37,700 stock options
New RSU grant
26,700 RSUs
Restricted stock units granted on June 18, 2026
Option vesting period
12 monthly installments
Vests after June 18, 2026, fully vested by June 18, 2027
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), exercise or conversion of derivative security, vesting
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) covering 37,700 shares of Common Stock was granted on June 18, 2026."
exercise or conversion of derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security."
vesting financial
"The option vests and becomes exercisable in twelve substantially equal monthly installments following June 18, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transactions did Polly A. Murphy report at Atea Pharmaceuticals (AVIR)?
Polly A. Murphy reported an RSU exercise into 29,600 Atea Pharmaceuticals common shares and new grants of 37,700 stock options and 26,700 restricted stock units, all dated June 18, 2026, as part of her director equity compensation.
What are the key terms of Polly A. Murphy’s new stock option grant at Atea Pharmaceuticals?
Murphy received options for 37,700 Atea Pharmaceuticals shares at an exercise price of $4.36 per share. The options vest in twelve substantially equal monthly installments after June 18, 2026 and are scheduled to be fully vested by June 18, 2027, subject to continued service.
How do Polly A. Murphy’s new restricted stock units at Atea Pharmaceuticals vest?
Murphy received 26,700 restricted stock units, each representing one Atea Pharmaceuticals common share. These RSUs vest in a single installment on the earlier of the next annual stockholder meeting after June 18, 2026 or June 18, 2027, contingent on her continued service.